MDS Inc. is suing Atomic Energy of Canada Ltd. and the federal government, seeking $1.6 billion over the cancellation of the MAPLE reactor project. The Toronto-based company, a major supplier of ...
Celgene and Acceleron Pharma are preparing to file their experimental myelodysplastic syndromes (MDS) therapy on both sides of the Atlantic on the back of promising data from a late-stage study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results